DRREDDY vs SBILIFE: Stock Comparison
SBI LIFE INSURANCE CO is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows a lower P/E, a higher dividend yield and faster revenue growth, while SBI LIFE INSURANCE CO shows a higher ROE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 6; SBILIFE leads 3 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | SBILIFE |
|---|---|---|
| Sector | Healthcare | Financial Services |
| Industry | Pharmaceuticals | Life Insurance |
Price
| Metric | DRREDDY | SBILIFE |
|---|---|---|
| Live Price | ₹1,229.5 | ₹1,640 |
| Day Change | -0.77% | -0.18% |
| Volume | 15.5 L | 9.8 L |
| 52-Week High | ₹1,414.9 | ₹2,132 |
| 52-Week Low | ₹1,101 | ₹1,612.9 |
| Distance from 52W High | -13.1% | -23.08% |
Valuation
| Metric | DRREDDY | SBILIFE |
|---|---|---|
| Market Cap | ₹1.02 L Cr | ₹1.65 L Cr |
| P/E Ratio | 36.5x | 63.44x |
| P/B Ratio | 2.63x | 8.65x |
| EPS | ₹5.32 | ₹7.23 |
| Book Value | ₹458.03 | ₹190.24 |
| Dividend Yield | 0.65% | 0.16% |
Growth
| Metric | DRREDDY | SBILIFE |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | -82.2% |
| EPS Growth (TTM YoY) | -86.2% | -1.1% |
| Qtr Sales Growth | 7.33% | — |
| Qtr Profit Growth | 96.84% | — |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | DRREDDY | SBILIFE |
|---|---|---|
| ROE | 10.27% | 12.94% |
| ROCE | 12.07% | — |
| Net Margin | 12.76% | 2.48% |
| Operating Margin | 21.43% | 2.25% |
| Debt to Equity | 0.17x | 0x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | DRREDDY | SBILIFE |
|---|---|---|
| Promoter Holding | 26.63%▼ 0.01 pp | 55.31%▼ 0.01 pp |
| FII Holding | 31.39%▼ 0.68 pp | 20.68%▼ 0.27 pp |
| DII Holding | 31.88%▲ 0.14 pp | 20.07%▲ 0.41 pp |
| Public Holding | 9.9%▲ 0.55 pp | 3.94%▼ 0.12 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and SBI LIFE INSURANCE CO.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.